Barinthus Biotherapeutics plc (BRNS) — Defensive Interval Ratio
Barinthus Biotherapeutics plc (BRNS) has a Defensive Interval Ratio of 144 days as of June 2025. Defensive assets of $5.01 Million (cash $-, short-term investments $-, receivables $5.01 Million) cover 144 days of daily cash needs of $34.86K/day. Check BRNS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Barinthus Biotherapeutics plc Defensive Interval Ratio (2019–2024)
This chart shows how Barinthus Biotherapeutics plc's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 144 days, meaning defensive assets of $5.01 Million can fund 144 days of operations without new revenue. Also explore how fast is Barinthus Biotherapeutics plc growing its equity to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Barinthus Biotherapeutics plc (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Barinthus Biotherapeutics plc from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Barinthus Biotherapeutics plc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 303 days | $13.00 Million | $42.90K/day | $- | $- | ▲ +73 days |
| 2023 | 230 days | $7.94 Million | $34.52K/day | $- | $- | ▼ -308 days |
| 2022 | 538 days | $18.05 Million | $33.54K/day | $- | $- | ▲ +155 days |
| 2021 | 383 days | $11.72 Million | $30.57K/day | $- | $- | ▲ +359 days |
| 2020 | 25 days | $518.00K | $20.93K/day | $- | $- | ▼ -223 days |
| 2019 | 248 days | $3.91 Million | $15.76K/day | $- | $- | — |